125 related articles for article (PubMed ID: 8658058)
1. Serum level of interleukin-4 in patients with perennial allergic rhinitis during allergen-specific immunotherapy.
Ohashi Y; Nakai Y; Okamoto H; Ohno Y; Sakamoto H; Sugiura Y; Kakinoki Y; Tanaka A; Kishimoto K; Washio Y; Hayashi M
Scand J Immunol; 1996 Jun; 43(6):680-6. PubMed ID: 8658058
[TBL] [Abstract][Full Text] [Related]
2. Ten-year follow-up study of allergen-specific immunoglobulin E and immunoglobulin G4, soluble interleukin-2 receptor, interleukin-4, soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in serum of patients on immunotherapy for perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Kato A; Masamoto T; Sakamoto H; Yamada K
Scand J Immunol; 1998 Feb; 47(2):167-78. PubMed ID: 9496694
[TBL] [Abstract][Full Text] [Related]
3. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
4. Natural course of serum-specific immunoglobulin E and immunoglobulin G4 for a span of eight years in untreated patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Ohno Y; Okamoto H; Kakinoki Y; Masamoto T; Tanaka A; Hayashi M
Laryngoscope; 1997 Mar; 107(3):382-5. PubMed ID: 9121318
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy suppresses both Th1 and Th2 responses by allergen stimulation, but suppression of the Th2 response is a more important mechanism related to the clinical efficacy of immunotherapy for perennial allergic rhinitis.
Tanaka A; Ohashi Y; Kakinoki Y; Nakai Y
Scand J Immunol; 1998 Aug; 48(2):201-11. PubMed ID: 9716113
[TBL] [Abstract][Full Text] [Related]
6. Seasonal rise in interleukin-4 during pollen season is related to seasonal rise in specific IgE for pollens but not for mites.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Ohno Y; Sakamoto H; Kato A; Masamoto T; Washio Y; Yamada K
Acta Otolaryngol; 1998 Mar; 118(2):243-7. PubMed ID: 9583794
[TBL] [Abstract][Full Text] [Related]
7. Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis.
Tanaka A; Ohashi Y; Nakai Y
Ann Otol Rhinol Laryngol; 1999 Feb; 108(2):193-200. PubMed ID: 10030240
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble interleukin-2 receptor in patients with perennial allergic rhinitis before and after immunotherapy.
Ohashi Y; Nakai Y; Sakamoto H; Ohno Y; Sugiura Y; Okamoto H; Tanaka A; Kakinoki Y; Kishimoto K; Hayashi M
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):203-8. PubMed ID: 8814045
[TBL] [Abstract][Full Text] [Related]
9. Some immunological aspects of patients with rhinitis in Lebanon.
Abdelnoor AM; Kobeissy F; Farhat D; Hadi U
Immunopharmacol Immunotoxicol; 2002 May; 24(2):289-301. PubMed ID: 12066854
[TBL] [Abstract][Full Text] [Related]
10. [Determination of interleukins and IgG4 in patients with allergic rhinitis with and without immunotherapy].
Velázquez BL; Segura DL; Barbosa DE; Vázquez MI; Tapia JG; Altamirano SC; Feria AJ
Rev Alerg Mex; 2004; 51(4):139-44. PubMed ID: 15491078
[TBL] [Abstract][Full Text] [Related]
11. The kinetics of change in cytokine production by CD4 T cells during conventional allergen immunotherapy.
Benjaponpitak S; Oro A; Maguire P; Marinkovich V; DeKruyff RH; Umetsu DT
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):468-75. PubMed ID: 10069882
[TBL] [Abstract][Full Text] [Related]
12. Quantification of circulating house dust mite-specific IL-4- and IL-13-secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons.
Michaud B; Gouvis-Echraghi R; Candon S; Couderc R; Jais JP; Bach JF; Chatenoud L; Just J
Clin Exp Allergy; 2014 Feb; 44(2):222-30. PubMed ID: 24447084
[TBL] [Abstract][Full Text] [Related]
13. Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Kato A; Masamoto T; Yamada K; Hayashi M
Arch Otolaryngol Head Neck Surg; 1998 Dec; 124(12):1337-46. PubMed ID: 9865756
[TBL] [Abstract][Full Text] [Related]
14. Significant correlation between symptom score and IgG4 antibody titer following long-term immunotherapy for perennial allergic rhinitis.
Ohashi Y; Nakai Y; Okamoto H; Ohno Y; Sakamoto H; Tanaka A; Kakinoki Y
Ann Otol Rhinol Laryngol; 1997 Jun; 106(6):483-9. PubMed ID: 9199608
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
[TBL] [Abstract][Full Text] [Related]
16. Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy.
Rogala B; Glück J
J Investig Allergol Clin Immunol; 1999; 9(3):183-9. PubMed ID: 10412681
[TBL] [Abstract][Full Text] [Related]
17. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
19. [The serum level transformation of IFN-gamma, IL-4 and IgE before and after SIT in patients with allergic rhinitis].
Li Y; Li P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Apr; 27(8):397-9, 403. PubMed ID: 23858719
[TBL] [Abstract][Full Text] [Related]
20. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
